Contact us or schedule an appointment and let us help you discover how GLP-1 medications and comprehensive care can support your journey to a healthier, more vibrant you
This may change the paradigm of how we view overweight and obesity as cardiovascular risk factors and not just cosmetic concerns and will hopefully expand insurance coverage and access for these medications for weight loss, she says
The quality of imputation was assessed through density plots comparing original and imputed distributions for each variable within each brain region, ensuring the preservation of the original data structure ( Supplementary Fig
Insurance coverage is expanding but remains more variable than semaglutide coverage, partly because tirzepatide has been on the market for less time
And so, I think the most ethical thing to do is have that patient's own primary doctor figure out, in the context of their specific overall health, which GLP-1 is right for them